CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM NEW
Total 13F shares
4,173,806
Share change
+396,437
Total reported value
$25,878,000
Price per share
$6.20
Number of holders
19
Value change
+$2,469,381
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q3 2017

As of 30 Sep 2017, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,173,806 shares. The largest 10 holders included ACUTA CAPITAL PARTNERS, LLC, WELLINGTON MANAGEMENT GROUP LLP, ARS Investment Partners, LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, GEODE CAPITAL MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, BlackRock Inc., and Benchmark Capital Advisors. This page lists 19 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.